# A Study to Evaluate Cardiovascular Interactions Between Mirabegron and Tamsulosin

> **NCT01489696** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 48 (actual)

## Conditions studied

- Cardiovascular
- Healthy Subjects
- Pharmacokinetics

## Interventions

- **DRUG:** mirabegron
- **DRUG:** tamsulosin

## Key facts

- **NCT ID:** NCT01489696
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2013-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01489696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01489696, "A Study to Evaluate Cardiovascular Interactions Between Mirabegron and Tamsulosin". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01489696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*